Laboratorios Farmaceuticos ROVI SA
LSE:0ILL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Laboratorios Farmaceuticos ROVI SA
LSE:0ILL
|
ES |
|
C
|
Corticeira Amorim SGPS SA
ELI:COR
|
PT |
|
TXNM Energy Inc
NYSE:TXNM
|
US |
|
B
|
BGT Corporation PCL
SET:BGT
|
TH |
|
Denali Therapeutics Inc
NASDAQ:DNLI
|
US |
|
I
|
Izotropic Corp
CNSX:IZO
|
CA |
|
M
|
Mesoblast Ltd
F:LWB
|
AU |
|
C
|
Citizen Watch Co Ltd
OTC:CHCLY
|
JP |
|
B
|
Binakarya Jaya Abadi Tbk PT
IDX:BIKA
|
ID |
|
DLF Ltd
NSE:DLF
|
IN |
|
M
|
Mitsubishi Motors Corp
F:MMO
|
JP |
|
T
|
Telefonaktiebolaget LM Ericsson
XHAM:ERCB
|
SE |
|
P
|
PaperCorea Inc
KRX:001020
|
KR |
|
B
|
Bayer AG
XMUN:BAYN
|
DE |
|
Q
|
Qingco Inc
OTC:QING
|
CN |
|
P
|
Procore Technologies Inc
NYSE:PCOR
|
US |
|
H
|
Hextar Industries Bhd
KLSE:HEXIND
|
MY |
|
AI/ML Innovations Inc
F:42FB
|
CA |
|
Impero A/S
F:905
|
DK |
|
K
|
Kendrion NV
F:K3E
|
NL |
|
C
|
Compagnie De l'odet SE
OTC:FCODF
|
FR |
|
H
|
Hetzer Medical Indonesia Tbk PT
IDX:MEDS
|
ID |
|
Foraco International SA
TSX:FAR
|
FR |
|
S
|
SNS Network Technology Bhd
KLSE:SNS
|
MY |
Dividends
Dividend Yield
Laboratorios Farmaceuticos ROVI SA
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Laboratorios Farmaceuticos ROVI SA
0ILL have increased by 152%.
Payout Ratio
Laboratorios Farmaceuticos ROVI SA
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 0ILL is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
0ILL Price
Laboratorios Farmaceuticos ROVI SA
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -38% |
| Market Capitalization | 3B EUR |
| Shares Outstanding | 1 847 884 |
| Percentage of Shares Shorted |
N/A
|
